News
A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...
THURSDAY, June 5, 2025 (HealthDay News) — More American teenagers now use the weight-loss drug Wegovy, as doctors and ...
7h
HealthDay on MSNCPAP or Zepbound? Patients, doctors debate sleep apnea treatmentA clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...
Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...
Shares of weight-loss drug developer Metsera gained as much as 25% on Monday after the company's experimental drug helped patients lose weight in a small, early-stage trial, showing potential for a ...
Orforglipron (pronounced or-for-GLIP-ron) might be a mouthful to say, but Indianapolis-based Eli Lilly and Co. sees this ...
Early-stage study results suggest that a single shot of the company’s therapy, which works differently than GLP-1 medicines, ...
A UK watchdog is urging women on GLP-1 weight-loss drugs like Ozempic and Mounjaro to use effective forms of birth control after receiving more than 40 pregnancy-related reports linked to the ...
American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...
Health experts are raising concerns for women using popular weight loss medications, particularly GLP-1s like Wegovy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results